Exploring cardiovascular risk in subclinical hypothyroidism: The impact of TSHR gene expression and systemic biomarkers.

IF 1.4 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Journal of Cardiovascular and Thoracic Research Pub Date : 2026-03-30 eCollection Date: 2026-03-01 DOI:10.34172/jcvtr.026.33666
Manjusha Kottola, Desigamani Kanniyappan, Damodaran Boopathi, Jeyapal Vidhyadharan, Vishnu Manjerikattil Govindan, Vineetha Vijayan, Joby Paruthiparayil Jose, Jisha Anjali Madhavan Pillai, Rajitha Puthiya Purayil, Swathi Thoduvayil, Midhun Thazhissery Mohanan, Dinesh Roy Divakaran
{"title":"Exploring cardiovascular risk in subclinical hypothyroidism: The impact of TSHR gene expression and systemic biomarkers.","authors":"Manjusha Kottola, Desigamani Kanniyappan, Damodaran Boopathi, Jeyapal Vidhyadharan, Vishnu Manjerikattil Govindan, Vineetha Vijayan, Joby Paruthiparayil Jose, Jisha Anjali Madhavan Pillai, Rajitha Puthiya Purayil, Swathi Thoduvayil, Midhun Thazhissery Mohanan, Dinesh Roy Divakaran","doi":"10.34172/jcvtr.026.33666","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Subclinical hypothyroidism (SCH), defined by elevated thyroid-stimulating hormone (TSH) with normal thyroid hormone levels, affects approximately 3-8% of the population. Growing evidence indicates that thyroid-stimulating hormone receptor (TSHR) expression in cardiovascular tissues, together with systemic inflammation (IL-6) and oxidative stress (3-nitrotyrosine), may contribute to cardiovascular dysfunction in SCH. This study aimed to evaluate the association between TSHR gene expression and systemic biomarkers-hormonal, inflammatory, and oxidative-and to assess their predictive value for cardiovascular risk in SCH patients.</p><p><strong>Methods: </strong>A case-control design was adopted involving 150 SCH subjects and 150 age- and sex-matched healthy controls. Demographic and clinical data were collected using structured interviews. Fasting blood samples were analyzed for TSH (CLIA), IL-6, and 3-nitrotyrosine (ELISA), while TSHR gene expression was quantified using real-time PCR with GAPDH as an internal control. Statistical analyses were performed using Stata version 17.0.</p><p><strong>Results: </strong>Compared with controls, SCH patients showed significantly higher levels of TSH, IL-6, 3-nitrotyrosine, and TSHR gene expression (<i>P</i><0.05). Receiver operating characteristic (ROC) analysis revealed high diagnostic accuracy for these parameters. Although univariate analysis associated TSHR dysregulation with SCH, multivariate regression identified TSH as the only independent predictor of disease status. Oxidative stress demonstrated a significant positive association with TSHR expression, whereas IL-6 showed no independent influence.</p><p><strong>Conclusion: </strong>SCH is characterized by elevated hormonal, oxidative, and inflammatory markers, with oxidative stress contributing to TSHR upregulation. TSH remains the strongest independent predictor, underscoring the hormonal-oxidative interaction in cardiovascular risk among SCH patients.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"18 1","pages":"46-54"},"PeriodicalIF":1.4000,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13309705/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular and Thoracic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jcvtr.026.33666","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Subclinical hypothyroidism (SCH), defined by elevated thyroid-stimulating hormone (TSH) with normal thyroid hormone levels, affects approximately 3-8% of the population. Growing evidence indicates that thyroid-stimulating hormone receptor (TSHR) expression in cardiovascular tissues, together with systemic inflammation (IL-6) and oxidative stress (3-nitrotyrosine), may contribute to cardiovascular dysfunction in SCH. This study aimed to evaluate the association between TSHR gene expression and systemic biomarkers-hormonal, inflammatory, and oxidative-and to assess their predictive value for cardiovascular risk in SCH patients.

Methods: A case-control design was adopted involving 150 SCH subjects and 150 age- and sex-matched healthy controls. Demographic and clinical data were collected using structured interviews. Fasting blood samples were analyzed for TSH (CLIA), IL-6, and 3-nitrotyrosine (ELISA), while TSHR gene expression was quantified using real-time PCR with GAPDH as an internal control. Statistical analyses were performed using Stata version 17.0.

Results: Compared with controls, SCH patients showed significantly higher levels of TSH, IL-6, 3-nitrotyrosine, and TSHR gene expression (P<0.05). Receiver operating characteristic (ROC) analysis revealed high diagnostic accuracy for these parameters. Although univariate analysis associated TSHR dysregulation with SCH, multivariate regression identified TSH as the only independent predictor of disease status. Oxidative stress demonstrated a significant positive association with TSHR expression, whereas IL-6 showed no independent influence.

Conclusion: SCH is characterized by elevated hormonal, oxidative, and inflammatory markers, with oxidative stress contributing to TSHR upregulation. TSH remains the strongest independent predictor, underscoring the hormonal-oxidative interaction in cardiovascular risk among SCH patients.

探讨亚临床甲状腺功能减退的心血管风险:TSHR基因表达和系统生物标志物的影响。
亚临床甲状腺功能减退症(SCH),定义为促甲状腺激素(TSH)升高而甲状腺激素水平正常,影响约3-8%的人群。越来越多的证据表明,促甲状腺激素受体(TSHR)在心血管组织中的表达,以及全身炎症(IL-6)和氧化应激(3-硝基酪氨酸)可能导致SCH患者的心血管功能障碍。本研究旨在评估TSHR基因表达与全身生物标志物(激素、炎症和氧化)之间的关系,并评估其对SCH患者心血管风险的预测价值。方法:采用病例对照设计,包括150名青少年和150名年龄、性别匹配的健康对照。采用结构化访谈收集人口统计和临床数据。空腹血样本进行TSH (CLIA)、IL-6、3-硝基酪氨酸(ELISA)检测,以GAPDH为内对照,采用实时荧光定量PCR法定量TSHR基因表达。使用Stata 17.0版本进行统计分析。结果:与对照组相比,SCH患者TSH、IL-6、3-硝基酪氨酸水平和TSHR基因表达均显著升高(结论:SCH以激素、氧化和炎症标志物升高为特征,氧化应激导致TSHR上调。TSH仍然是最强的独立预测因子,强调了SCH患者心血管风险中的激素-氧化相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cardiovascular and Thoracic Research
Journal of Cardiovascular and Thoracic Research CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.00
自引率
0.00%
发文量
22
审稿时长
7 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书